The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.


Updates from The Motley Fool

Latest updates on ResMed from Fool.com.  The Fool has written over 100 articles on ResMed.
Why ResMed Shares Were Rocked

ResMed delivers double-digit EPS growth for the quarter but fails to live up to Wall Street's lof...



Stock Performance

View Interactive RMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about ResMed.
Current Price: $71.96
Prev Close: $71.62
Open: $70.71
Bid: $71.93
Ask: $71.95
Day's Range: $70.71 - $72.03
52wk Range: $55.13 - $72.70
Volume: 476,411
Avg Vol 1,002,850
Market Cap: $10B
P/E (ttm): 31.00
EPS (ttm): $2.31
Div & Yield: $1.32 (1.8%)

Company Rating

What our community thinks about ResMed.
CAPS Rating 3 out of 5
 
223 Outperform
14 Underperform
CAPS All Stars
 
61 Outperform
4 Underperform

How do you think ResMed will perform against the market?



You pick for ResMed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael "Mick" Farrell, CEO

91% Approve

Based on 102 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ResMed.

The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT